Do Evofem Biosciences Inc. (EVFM) beta value of -0.28 signposts another twist? – Invest Chronicle
Home  »  Industry   »  Do Evofem Biosciences Inc. (EVFM) beta value of -0...

Do Evofem Biosciences Inc. (EVFM) beta value of -0.28 signposts another twist?

For the readers interested in the stock health of Evofem Biosciences Inc. (EVFM). It is currently valued at $0.88. When the transactions were called off in the previous session, Stock hit the highs of $0.914, after setting-off with the price of $0.8691. Company’s stock value dipped to $0.865 during the trading on the day. When the trading was stopped its value was $0.90.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on June 1, 2021, Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021. Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:. You can read further details here


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Evofem Biosciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.5300 on 02/17/21, with the lowest value was $0.7510 for the same time period, recorded on 05/26/21.

Evofem Biosciences Inc. (EVFM) full year performance was -82.27%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Evofem Biosciences Inc. shares are logging -84.17% during the 52-week period from high price, and 16.54% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $5.53.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4390046 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Evofem Biosciences Inc. (EVFM) recorded performance in the market was -62.77%, having the revenues showcasing -77.28% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 86.60M, as it employees total of 147 workers.

Specialists analysis on Evofem Biosciences Inc. (EVFM)

During the last month, 2 analysts gave the Evofem Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.3200, with a change in the price was noted -1.6540. In a similar fashion, Evofem Biosciences Inc. posted a movement of -65.38% for the period of last 100 days, recording 6,715,161 in trading volumes.

Trends and Technical analysis: Evofem Biosciences Inc. (EVFM)

Raw Stochastic average of Evofem Biosciences Inc. in the period of last 50 days is set at 6.60%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 19.41%. In the last 20 days, the company’s Stochastic %K was 18.14% and its Stochastic %D was recorded 15.42%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -62.77%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -60.82%, alongside a downfall of -82.27% for the period of the last 12 months. The shares increased approximately by 8.79% in the 7-day charts and went up by -39.37% in the period of the last 30 days. Common stock shares were lifted by -77.28% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam